The Conference of the Parties serving as the meeting of the Parties to this Protocol shall, at its first meeting, consider and approve cooperative procedures and. An Explanatory Guide to the Cartagena Protocol on Biosafety. IUCN Environmental Law Paper No. pages x G. M. La Vina and Ruth Mackenzie. An Explanatory Guide to the Cartagena Protocol on Biosafety: IUCN Environmental Law Paper No. 46 (Environmental Policy & Law Papers) [G. M. La Vina, Ruth.

Author: Mikagor Shasida
Country: Colombia
Language: English (Spanish)
Genre: Relationship
Published (Last): 25 August 2010
Pages: 35
PDF File Size: 16.17 Mb
ePub File Size: 12.37 Mb
ISBN: 198-6-41011-340-9
Downloads: 98556
Price: Free* [*Free Regsitration Required]
Uploader: Akinorr

The compliance mechanism was developed on the basis of Article 8 of the Montreal Protocol. The body considers the matter and issues a recommendation for resolving the problem. As an information center, the BCH also provides access to other biosafety information exchange mechanisms such as information available on the United Nations Industrial Organization — Biosafety Information Network and Advisory Services.

The procedure for AIA is covered under Articles 7 to 10 and 12; and requires that a Party of Export shall notify in writing to a competent national authority of the Party of Import of an intentional transboundary movement 20 for the intentional release into the environment; Art.

It is worth noting that while most multilateral environmental agreements, like the CBD, provide procedures for dispute settlement, these tend to be optional and have not, in practice, been used.

An Explanatory Guide to the Cartagena Protocol on Biosafety

A declaration that the movement conforms to the requirement of the Protocol should be included by the exporter. To promote compliance, to address cases of non-compliance, and to provide advice or assistance to Parties to help them comply Nature: Cartagena Protocol on Biosafety, Article 24 Examples of LMOs-FFP 21 include corn, soya bean, wheat or other grains that will be directly fed to humans or animals or used for processing.

Under the Vienna Convention of the Law of Treaties, a Protocol cannot create rights and obligations for non-parties without their consent Text of the Protocol: The right of any Party to subject any living modified organism intended for human pharmaceutical to risk assessment is left at the discretion of each Party as the exemption in Article 5 is without prejudice to any right of a Party to subject all living modified organisms to risk assessment prior to making of decisions on import In some instances, the Parties concerned have to report back on measures taken in accordance with the recommendations.


Transboundary The Primary focus of the Cartagena Protocol is the regulation of transboundary movement of living modified organisms. Article 3 k of the Cartagena Protocol defines Transboundary Movement as: Id Article 36 5. To examine cases of possible non-compliance, with a view to proposing a solution, and to make recommendations for concrete responses to the Parties concerned or to the Conference of the Parties to the agreement.

The history of the Cartagena Protocol is well documented and the table below provides a brief summary of the negotiations.

Rio Declaration on Environment and Development, available here In the event of a dispute between Contracting Parties concerning the interpretation or application of this Convention, the parties concerned shall seek solution by negotiation. See Box 50 below. This means that where the affected or potentially affected State is not a Party to the Cartagena Protocol, it must be notified in line with principles of international customary laws.

The road to the Cartagena Protocol on Biosafety Phase 1: It has been operational for several years. A Party dealing with a non-Party has the burden to ensure that any bilateral, regional and multilateral agreements and arrangements on transboundary movements of living modified organisms are consistent with the objectives of the Protocol.

The Cartagena Protocol on Biosafety is the first multilateral international treaty dealing with the transboundary movement of living modified organisms commonly referred to as genetically modified organisms. The Party of Import may also subject the LMO destined for contained use to risk assessment prior to any prtoocol. A Party to any protocol is a State that has consented to be bound by the treaty by signing and agreeing to be bound by the Objectives of the Treaty.

The Cartagena Protocol does not elaborate on the issue of adequacy of protection, thus each Party dxplanatory the discretion to include the standard it desires. The mechanisms adopted under the various other multilateral environment agreements adopt different approaches to some of these elements.

Compliance procedures and mechanisms adopted, or under development, under other multilateral environment agreements to date tend to include a number of common core elements and characteristics. Generally, each category of LMO has different documentation requirements under the Protocol as follows: These categories of LMOs explamatory minimal environmental risk as they are not to be introduced to the environment.

The Primary focus of the Cartagena Protocol is the regulation of transboundary movement of living modified organisms. The Party or Parties concerned may not participate in the adoption of the recommendations or in the biosafett of the report.


After several years of work, a compliance mechanism was adopted for the Kyoto Protocol at the 7th meeting of the Conference niosafety the Parties to the Convention in Intentional transboundary movement between Parties and non-parties is regulated through Article 24 of the Protocol which provides that such movements shall be consistent with the objective of the Cartagena Protocol It operates independently of, and without prejudice biisafety, the dispute settlement procedure as laid down in Article xeplanatory of the parent treaty to the Protocol, the Vienna Convention for the Protection of the Ozone Layer.

The Committee meets twice a year. Supra at 13 When ratifying, accepting, approving or acceding to this Convention, or at any time thereafter, a State or regional economic integration organization may declare in writing to the Depositary that for a dispute not resolved biosafetty accordance with paragraph 1 or paragraph 2 above, it accepts one or both of the following means of dispute settlement as compulsory:.

Under Article 24 2 Parties are to encourage non-Parties to adhere to the Protocol and to contribute appropriate information to the Biosafety Clearing-House on living Modified Organisms released in, or moved into or out of, areas within their national jurisdictions.

An Explanatory Guide to the Cartagena Protocol on Biosafety

If the parties to the dispute have not, in accordance with paragraph 3 above, accepted the same or any procedure, the dispute shall be explanatorh to conciliation in accordance with Part 2 of Annex II unless the parties otherwise agree. This means that under the domestic regulatory framework, a Party may require the LMO-FFPs to be subjected to advance notification and approval.

Background to the Cartagena Protocol on Biosafety General Information Footnotes General Information Introduction Efforts to create international Biosafety rules began in the s, when modern biotechnology was still at its infancy but showing signs of progressing towards the commercialization of genetically modified organisms and products.

The Implementation Committee considers the matters submitted to it.

Id, Article 5 Article 5 of the Protocol exempts the transboundary movement of living modified organisms which are pharmaceuticals for humans Text of the Convention on Biological Diversity, available at http: The Cartagena Protocol is essentially a multilateral environmental agreement MEA to regulate environmental issues related to the intentional movement of living modified organisms.